Cannara Biotech Balance Sheet Health
Financial Health criteria checks 3/6
Cannara Biotech has a total shareholder equity of CA$81.8M and total debt of CA$48.2M, which brings its debt-to-equity ratio to 58.9%. Its total assets and total liabilities are CA$148.8M and CA$67.0M respectively. Cannara Biotech's EBIT is CA$8.6M making its interest coverage ratio 1.8. It has cash and short-term investments of CA$5.5M.
Key information
58.9%
Debt to equity ratio
CA$48.17m
Debt
| Interest coverage ratio | 1.8x |
| Cash | CA$5.46m |
| Equity | CA$81.77m |
| Total liabilities | CA$67.00m |
| Total assets | CA$148.77m |
Recent financial health updates
Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?
Jul 14
Is Cannara Biotech (CVE:LOVE) A Risky Investment?
Jul 29Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden
Jan 26Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet
Dec 10Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt
Mar 16Recent updates
Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings
Aug 22Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue
Aug 21Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?
Jul 14Cannara Biotech Inc.'s (CVE:LOVE) Prospects Need A Boost To Lift Shares
May 09Here's Why We Think Cannara Biotech (CVE:LOVE) Might Deserve Your Attention Today
Feb 28Investor Optimism Abounds Cannara Biotech Inc. (CVE:LOVE) But Growth Is Lacking
Jan 24Cannara Biotech's (CVE:LOVE) Earnings May Just Be The Starting Point
Dec 18Is Cannara Biotech (CVE:LOVE) A Risky Investment?
Jul 29Cannara Biotech Inc.'s (CVE:LOVE) Business Is Yet to Catch Up With Its Share Price
Apr 10Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden
Jan 26Cannara Biotech's (CVE:LOVE) Earnings Aren't As Good As They Appear
Jan 27Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet
Dec 10Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt
Mar 16Can You Imagine How Cannara Biotech's (CSE:LOVE) Shareholders Feel About The -6.5% Share Price Increase?
Jan 22
Have Insiders Been Buying Cannara Biotech Inc. (CSE:LOVE) Shares?
Dec 18Financial Position Analysis
Short Term Liabilities: LOVE's short term assets (CA$62.0M) exceed its short term liabilities (CA$26.8M).
Long Term Liabilities: LOVE's short term assets (CA$62.0M) exceed its long term liabilities (CA$40.2M).
Debt to Equity History and Analysis
Debt Level: LOVE's net debt to equity ratio (52.2%) is considered high.
Reducing Debt: LOVE's debt to equity ratio has increased from 30.5% to 58.9% over the past 5 years.
Debt Coverage: LOVE's debt is well covered by operating cash flow (20.6%).
Interest Coverage: LOVE's interest payments on its debt are not well covered by EBIT (1.8x coverage).